Sensus Healthcare Installs an SRT-100™ at Froedtert & The Medical College of Wisconsin Cancer Center and Commences Collaborative Research Relationship

Press Release

September 24, 2012

Boca Raton, FL

Sensus Healthcare is pleased to announce that Froedtert & The Medical College of Wisconsin Cancer Center has chosen the SRT-100™ advanced superficial radiotherapy platform (SRT) as the latest addition to its comprehensive radiotherapy solutions for cancer. Froedtert & The Medical College Cancer Center is the first cancer center in Wisconsin to offer this advanced, non-invasive radiotherapy solution to treat non-melanoma skin cancers.

The SRT-100™ technology is a compact, easily portable device that uses low-energy radiotherapy to concentrate the radiation dose on the skin surface, offering doctors an alternative to surgery for non-melanoma skin cancers.

“Our patient healing philosophy drives us to approach skin cancer in a multidisciplinary fashion – from diagnosis to therapy to cure. We approach each patient individually when treating their skin cancer by employing personally tailored protocols and treatment modalities to maximize clinical outcomes. The SRT-100™ expands our options of treatment modalities and augments our capabilities,” said J. Frank Wilson, MD, director of adult cancer services for Froedtert & The Medical College of Wisconsin and Chairman, Director Emeritus, Cancer Center, Bernard & Miriam Peck Family Professor of Radiation Oncology.

In addition, Sensus and Froedtert & The Medical College of Wisconsin will enter into a collaborative research relationship through which they will pursue studying and discovering novel treatment methods for skin cancer.

“We understand and appreciate Dr Wilson’s long-time passion and dedication to a comprehensive approach in treating skin cancer,” said Joe Sardano, President/CEO, Sensus Healthcare. “We are honored to have the opportunity to work with Dr. Wilson, Chief of Medical Physics Dr. Allen Li, and the entire staff of the Froedtert & The Medical College radiation oncology program as it provides Sensus with unique possibilities in furthering the capabilities of our technology and translating it to new areas of interest for the future treatment of skin cancers.”


About Sensus Healthcare:

Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings.


About Froedtert & The Medical College of Wisconsin

Froedtert & The Medical College of Wisconsin combine the strengths of Froedtert Hospital and The Medical College in an academic medical center that delivers advanced medical care. Froedtert & The Medical College are nationally recognized for exceptional physicians, research leadership, specialty expertise and state-of-the-science treatments and technology. For more information, visit and


Media Contact:
Michelle Verina
Public Relations
561-922-5808 Ext. 100

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

  1. 95%+ cure rates that rival surgery
  2. No anesthesia, cutting, bleeding, stitching or pain
  3. No downtime or lifestyle restrictions
  4. Super cosmesis, no unsightly scarring
  5. No need for post-treatment reconstructive surgeries